BL-4040

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBL-4040
Drug Alias Namepseudo-virus vector-delivered capsid protein VP1 (BioLineRx)pseudo-virus-delivered capsid protein VP1 (Gene Vector Technologies)BL-4040
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionApoptosis inhibitors
TargetsUpdating
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGene Vector Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx LtdGene Vector Technologies Ltd
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A